vs
GE医疗（CCRN）与ROYAL GOLD INC（RGLD）财务数据对比。点击上方公司名可切换其他公司
ROYAL GOLD INC的季度营收约是GE医疗的1.6倍（$375.3M vs $236.8M），ROYAL GOLD INC净利率更高（24.9% vs -35.0%，领先60.0%），ROYAL GOLD INC同比增速更快（85.3% vs -23.6%），过去两年ROYAL GOLD INC的营收复合增速更高（58.8% vs -21.0%）
GE医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，品牌标识为GE HealthCare。公司主要业务分为四大板块：包含分子影像、CT、磁共振、妇科筛查及X光设备的医学影像业务、超声业务，以及聚焦远程患者监测、麻醉呼吸护理、心脏诊断、婴幼儿护理的患者护理解决方案业务，此外还开展医药相关业务。
Royal Gold Inc.是全球领先的贵金属流权与特许权经营企业，收购并管理多元化的矿业项目流权、净熔炼收益特许权及相关权益，资产覆盖黄金、白银、铜等品类，业务遍及多地区，无需直接承担采矿运营风险。
CCRN vs RGLD — 直观对比
营收规模更大
RGLD
是对方的1.6倍
$236.8M
营收增速更快
RGLD
高出108.9%
-23.6%
净利率更高
RGLD
高出60.0%
-35.0%
两年增速更快
RGLD
近两年复合增速
-21.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $236.8M | $375.3M |
| 净利润 | $-82.9M | $93.6M |
| 毛利率 | — | 64.6% |
| 营业利润率 | -30.2% | 56.2% |
| 净利率 | -35.0% | 24.9% |
| 营收同比 | -23.6% | 85.3% |
| 净利润同比 | -2109.7% | -12.8% |
| 每股收益（稀释后） | $-2.56 | $1.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCRNRGLD
| Q4 25 | $236.8M | $375.3M | ||
| Q3 25 | $250.1M | $252.1M | ||
| Q2 25 | $274.1M | $209.6M | ||
| Q1 25 | $293.4M | $193.4M | ||
| Q4 24 | $309.9M | $202.6M | ||
| Q3 24 | $315.1M | $193.8M | ||
| Q2 24 | $339.8M | $174.1M | ||
| Q1 24 | $379.2M | $148.9M |
净利润CCRNRGLD
| Q4 25 | $-82.9M | $93.6M | ||
| Q3 25 | $-4.8M | $126.8M | ||
| Q2 25 | $-6.7M | $132.3M | ||
| Q1 25 | $-490.0K | $113.5M | ||
| Q4 24 | $-3.8M | $107.4M | ||
| Q3 24 | $2.6M | $96.2M | ||
| Q2 24 | $-16.1M | $81.2M | ||
| Q1 24 | $2.7M | $47.2M |
毛利率CCRNRGLD
| Q4 25 | — | 64.6% | ||
| Q3 25 | 20.4% | 73.6% | ||
| Q2 25 | 20.4% | 72.6% | ||
| Q1 25 | 20.0% | 69.4% | ||
| Q4 24 | — | 70.3% | ||
| Q3 24 | 20.4% | 66.6% | ||
| Q2 24 | 20.8% | 64.7% | ||
| Q1 24 | 20.4% | 58.4% |
营业利润率CCRNRGLD
| Q4 25 | -30.2% | 56.2% | ||
| Q3 25 | -2.4% | 64.4% | ||
| Q2 25 | -2.1% | 67.7% | ||
| Q1 25 | -0.3% | 63.6% | ||
| Q4 24 | -1.1% | 65.9% | ||
| Q3 24 | 0.9% | 61.3% | ||
| Q2 24 | -5.7% | 58.6% | ||
| Q1 24 | 0.8% | 50.7% |
净利率CCRNRGLD
| Q4 25 | -35.0% | 24.9% | ||
| Q3 25 | -1.9% | 50.3% | ||
| Q2 25 | -2.4% | 63.1% | ||
| Q1 25 | -0.2% | 58.7% | ||
| Q4 24 | -1.2% | 53.0% | ||
| Q3 24 | 0.8% | 49.7% | ||
| Q2 24 | -4.7% | 46.6% | ||
| Q1 24 | 0.7% | 31.7% |
每股收益（稀释后）CCRNRGLD
| Q4 25 | $-2.56 | $1.04 | ||
| Q3 25 | $-0.15 | $1.92 | ||
| Q2 25 | $-0.20 | $2.01 | ||
| Q1 25 | $-0.02 | $1.72 | ||
| Q4 24 | $-0.13 | $1.63 | ||
| Q3 24 | $0.08 | $1.46 | ||
| Q2 24 | $-0.47 | $1.23 | ||
| Q1 24 | $0.08 | $0.72 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $108.7M | $233.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $322.8M | $7.2B |
| 总资产 | $449.0M | $9.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CCRNRGLD
| Q4 25 | $108.7M | $233.7M | ||
| Q3 25 | $99.1M | $172.8M | ||
| Q2 25 | $81.2M | $248.2M | ||
| Q1 25 | $80.7M | $240.8M | ||
| Q4 24 | $81.6M | $195.5M | ||
| Q3 24 | $64.0M | $127.9M | ||
| Q2 24 | $69.6M | $74.2M | ||
| Q1 24 | $5.2M | $137.9M |
总债务CCRNRGLD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $50.0M | ||
| Q1 24 | — | — |
股东权益CCRNRGLD
| Q4 25 | $322.8M | $7.2B | ||
| Q3 25 | $408.1M | $3.4B | ||
| Q2 25 | $412.2M | $3.3B | ||
| Q1 25 | $418.2M | $3.2B | ||
| Q4 24 | $419.0M | $3.1B | ||
| Q3 24 | $424.7M | $3.0B | ||
| Q2 24 | $433.3M | $3.0B | ||
| Q1 24 | $462.4M | $2.9B |
总资产CCRNRGLD
| Q4 25 | $449.0M | $9.5B | ||
| Q3 25 | $538.2M | $4.5B | ||
| Q2 25 | $553.8M | $3.6B | ||
| Q1 25 | $576.2M | $3.5B | ||
| Q4 24 | $589.3M | $3.4B | ||
| Q3 24 | $597.4M | $3.3B | ||
| Q2 24 | $602.9M | $3.3B | ||
| Q1 24 | $648.4M | $3.3B |
负债/权益比CCRNRGLD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.02× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.2M | $241.7M |
| 自由现金流经营现金流 - 资本支出 | $16.1M | — |
| 自由现金流率自由现金流/营收 | 6.8% | — |
| 资本支出强度资本支出/营收 | 0.9% | — |
| 现金转化率经营现金流/净利润 | — | 2.58× |
| 过去12个月自由现金流最近4个季度 | $40.1M | — |
8季度趋势，按日历期对齐
经营现金流CCRNRGLD
| Q4 25 | $18.2M | $241.7M | ||
| Q3 25 | $20.1M | $174.0M | ||
| Q2 25 | $4.2M | $152.8M | ||
| Q1 25 | $5.7M | $136.4M | ||
| Q4 24 | $24.2M | $141.1M | ||
| Q3 24 | $7.5M | $136.7M | ||
| Q2 24 | $82.4M | $113.5M | ||
| Q1 24 | $6.0M | $138.3M |
自由现金流CCRNRGLD
| Q4 25 | $16.1M | — | ||
| Q3 25 | $17.9M | — | ||
| Q2 25 | $2.3M | — | ||
| Q1 25 | $3.8M | — | ||
| Q4 24 | $21.7M | — | ||
| Q3 24 | $6.3M | — | ||
| Q2 24 | $79.6M | — | ||
| Q1 24 | $3.8M | — |
自由现金流率CCRNRGLD
| Q4 25 | 6.8% | — | ||
| Q3 25 | 7.2% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 7.0% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 23.4% | — | ||
| Q1 24 | 1.0% | — |
资本支出强度CCRNRGLD
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | 0.6% | — |
现金转化率CCRNRGLD
| Q4 25 | — | 2.58× | ||
| Q3 25 | — | 1.37× | ||
| Q2 25 | — | 1.15× | ||
| Q1 25 | — | 1.20× | ||
| Q4 24 | — | 1.31× | ||
| Q3 24 | 2.92× | 1.42× | ||
| Q2 24 | — | 1.40× | ||
| Q1 24 | 2.23× | 2.93× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
RGLD
| Gold | $216.9M | 58% |
| Pueblo Viejo | $47.3M | 13% |
| Andacollo | $32.6M | 9% |
| Silver | $32.1M | 9% |
| Other | $27.2M | 7% |
| Copper | $13.7M | 4% |
| Cortez Legacy Zone | $5.4M | 1% |
